Table 1.
The correlation between circ-ADD3 expression and clinicopathologic features of HCC patients (n=112)
| Features | circ-ADD3 expression | P Value | |
|---|---|---|---|
|
| |||
| Low (n=56) | High (n=56) | ||
| Age | 0.571 | ||
| ≤ 50 | 26 | 29 | |
| > 50 | 30 | 27 | |
| Gender | 0.483 | ||
| Male | 46 | 43 | |
| Female | 10 | 13 | |
| AFP (ng/ml) | 0.393 | ||
| ≤ 400 | 17 | 13 | |
| > 400 | 39 | 43 | |
| HBV | 0.249 | ||
| Positive | 36 | 30 | |
| Negative | 20 | 26 | |
| Liver cirrhosis | 0.393 | ||
| Yes | 39 | 43 | |
| No | 17 | 13 | |
| Tumor diameter (cm) | 0.088 | ||
| ≤ 5 | 26 | 35 | |
| > 5 | 30 | 21 | |
| Vascular invasion | 0.023 | ||
| Yes | 33 | 21 | |
| No | 23 | 35 | |
| Intrahepatic metastasis | 0.018 | ||
| Yes | 20 | 9 | |
| No | 36 | 47 | |
| Distant metastasis | 0.007 | ||
| Yes | 13 | 3 | |
| No | 43 | 53 | |
| Edmondson | 0.200 | ||
| I-II | 18 | 12 | |
| III-IV | 38 | 44 | |